HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Fröhling Selected Research

Carbon

2/2021Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Fröhling Research Topics

Disease

14Neoplasms (Cancer)
06/2022 - 04/2001
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 04/2001
2Sarcoma (Soft Tissue Sarcoma)
01/2022 - 02/2021
2Skin Neoplasms (Skin Cancer)
12/2021 - 01/2017
2Chromosome Aberrations (Chromosome Abnormalities)
06/2015 - 04/2015
2Pathologic Complete Response
11/2004 - 08/2003
1Eccrine Porocarcinoma
12/2021
1Neoplasm Metastasis (Metastasis)
12/2021
1Adenocarcinoma of Lung
10/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Cardiotoxicity
11/2020
1Aggressive Fibromatosis (Desmoid)
06/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017
1Carcinoma (Carcinomatosis)
01/2017
1Gallbladder Neoplasms (Gallbladder Cancer)
05/2016
1Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2016
1Acute Promyelocytic Leukemia
06/2005
1Lymphopenia (Lymphocytopenia)
03/2004
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2004
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2004
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2001

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2001
2Biological ProductsIBA
01/2022 - 02/2021
2Immune Checkpoint InhibitorsIBA
10/2021 - 01/2019
2Messenger RNA (mRNA)IBA
10/2021 - 03/2004
2AntibodiesIBA
10/2017 - 05/2016
2Mitoxantrone (Novantrone)FDA LinkGeneric
06/2005 - 08/2003
2Cytarabine (Cytosar-U)FDA LinkGeneric
06/2005 - 08/2003
1PlatinumIBA
06/2022
1Delta CateninIBA
12/2021
1B7-H1 AntigenIBA
12/2021
12-methylphenyl cinnamateIBA
12/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
12/2021
1erucylphosphocholineIBA
12/2021
1Phosphotransferases (Kinase)IBA
12/2021
1Protons (Proton)IBA
02/2021
1CarbonIBA
02/2021
1IonsIBA
02/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
10/2017
1DNA (Deoxyribonucleic Acid)IBA
10/2017
1RNA (Ribonucleic Acid)IBA
10/2017
1regorafenibIBA
01/2017
1Imatinib Mesylate (Gleevec)FDA Link
01/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1130-nm albumin-bound paclitaxelIBA
05/2016
1Cisplatin (Platino)FDA LinkGeneric
05/2016
1GemcitabineFDA Link
05/2016
1Trastuzumab (Herceptin)FDA Link
05/2016
1pertuzumabIBA
05/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2016
1NucleotidesIBA
06/2015
1TOR Serine-Threonine KinasesIBA
04/2015
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2015
1MicroRNAs (MicroRNA)IBA
02/2013
1N 30IBA
11/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2004
1Insulin (Novolin)FDA Link
03/2004
1Etoposide (VP 16)FDA LinkGeneric
08/2003
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
08/2003
1Origin Recognition ComplexIBA
04/2001

Therapy/Procedure

12Therapeutics
12/2021 - 08/2003
2Drug Therapy (Chemotherapy)
06/2022 - 11/2004
1Precision Medicine
01/2022
1Heavy Ion Radiotherapy
02/2021
1Radiotherapy
06/2020
1Investigational Therapies (Experimental Therapy)
10/2017
1Salvage Therapy
01/2017